Clinical Application of Precise Hepatectomy in Treatment of Hepatolithiasis

Objective: To explore the clinical value of precise hepatectomy in treatment of hepatolithiasis. Method: 128 patients with hepatolithiasis admitted into this hospital from Jun., 2008 to Jun., 2013 who were recruited, and they were assigned into 2 groups in this prospective, non-randomized controlled clinical trial: precise hepatectomy group(n=68) and irregular hepatectomy group(n=60). The operative time, blood loss, postoperative complications, length of stay, stone clearance rate, and stones recurrence between both groups were compared. Result: The blood loss, ALT peak, AST peak, TBIL peak, and length of stay in precise hepatectomy group were better than those in irregular hepatectomy group. The stone residual rate, incidence of complications, and recurrence rate in precise hepatectomy group(8.8%, 11.8%, 5.9%) were lower than those in irregular hepatectomy group(21.7%, 23.3%, 16.7%). Conclusion: The precision hepatectomy for the treatment of hepatolithiasis has definite efficacy, and can shorten the patient rehabilitation period and reduce postoperative stone residual rate and incidence of complications, recurrence.